randomized 1
study 1
melphalan 1
mgm 2
vs 1
preparative 1
regimen 1
patients 1
multiple 1
myeloma 1
undergoing 1
autosct 1
low 1
serum 1
vitamin 1
d 1
levels 1
associated 1
inferior 1
survival 1
follicular 2
lymphoma 2
prospective 1
evaluation 1
swog 1
lysa 1
studies 1
comparative 1
analysis 1
prognostic 1
factor 1
models 1
based 1
phase 1
iii 1
trial 1
choprituximab 1
versus 1
chop 1
iodinetositumomab 1
